Header cover image

South Korean (KOSPI) Life Sciences Industry Analysis

UpdatedJun 16, 2025
DataAggregated Company Financials
Companies29
  • 7D1.0%
  • 3M-1.6%
  • 1Y43.4%
  • YTD10.8%

Over the last 7 days, the Life Sciences industry has remained flat, although notably Peptron gained 18%. As for the the longer term, the industry is up 43% over the past 12 months. Looking forward, earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the South Korean Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 16 Jun 2025₩83.2t₩5.6t₩1.2t15.3x67.5x14.8x
Wed, 14 May 2025₩81.7t₩5.2t₩1.0t18.4x79.7x15.6x
Fri, 11 Apr 2025₩81.4t₩5.2t₩1.0t16.8x79.2x15.6x
Sun, 09 Mar 2025₩86.6t₩5.2t₩996.4b12.4x86.9x16.7x
Tue, 04 Feb 2025₩86.8t₩5.0t₩965.6b12.2x89.9x17.3x
Thu, 02 Jan 2025₩75.9t₩5.0t₩965.6b13x78.6x15.2x
Sat, 30 Nov 2024₩76.7t₩5.0t₩945.9b14.3x81.1x15.3x
Mon, 28 Oct 2024₩84.7t₩4.8t₩885.3b13.1x95.6x17.5x
Wed, 25 Sep 2024₩84.5t₩4.8t₩885.3b14.9x95.5x17.4x
Fri, 23 Aug 2024₩74.7t₩4.8t₩863.7b15.7x86.5x15.5x
Sun, 21 Jul 2024₩66.5t₩4.5t₩731.7b17.9x90.9x14.6x
Tue, 18 Jun 2024₩58.0t₩4.6t₩691.8b19.3x83.9x12.6x
Thu, 16 May 2024₩61.3t₩4.4t₩635.1b20.2x96.5x14x
Sat, 13 Apr 2024₩62.7t₩4.7t₩654.7b18.9x95.7x13.4x
Mon, 11 Mar 2024₩66.4t₩4.6t₩635.2b34.5x104.5x14.3x
Wed, 07 Feb 2024₩65.6t₩4.5t₩714.4b33.7x91.8x14.5x
Fri, 05 Jan 2024₩61.2t₩4.5t₩721.5b32.7x84.9x13.5x
Sun, 03 Dec 2023₩56.3t₩4.5t₩721.6b31.7x78x12.4x
Tue, 31 Oct 2023₩56.3t₩4.4t₩660.9b21.8x85.2x12.8x
Thu, 28 Sep 2023₩54.3t₩4.4t₩660.9b30.3x82.1x12.3x
Sat, 26 Aug 2023₩59.8t₩4.2t₩657.9b28.9x90.9x14.3x
Mon, 24 Jul 2023₩58.7t₩4.2t₩673.4b29.2x87.2x14x
Wed, 21 Jun 2023₩59.8t₩4.2t₩666.5b29.5x89.8x14.1x
Fri, 19 May 2023₩61.1t₩4.1t₩626.3b27.2x97.5x14.9x
Sun, 16 Apr 2023₩64.0t₩4.1t₩626.3b30.5x102.3x15.7x
Tue, 14 Mar 2023₩60.8t₩4.0t₩718.4b20.1x84.6x15.2x
Thu, 09 Feb 2023₩63.5t₩3.5t₩427.8b21.1x148.5x18.2x
Sat, 07 Jan 2023₩63.0t₩3.4t₩428.7b21.1x147.1x18.3x
Mon, 05 Dec 2022₩67.3t₩3.4t₩428.7b18.7x157x19.6x
Wed, 02 Nov 2022₩68.0t₩3.0t₩448.5b23.6x151.7x22.8x
Fri, 30 Sep 2022₩63.2t₩3.0t₩448.5b21.6x140.9x21.2x
Sun, 28 Aug 2022₩66.7t₩2.9t₩479.8b26.4x139.1x22.7x
Tue, 26 Jul 2022₩65.4t₩2.7t₩454.7b28.3x143.8x24.1x
Thu, 23 Jun 2022₩64.2t₩2.7t₩454.7b25.8x141.1x23.6x
Price to Earnings Ratio

141.1x


Total Market Cap: ₩64.2tTotal Earnings: ₩454.7bTotal Revenue: ₩2.7tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Life Sciences Industry Price to Earnings3Y Average 102.4x202320242025
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 67.5x which is lower than its 3-year average PE of 102x.
  • The industry is trading close to its 3-year average PS ratio of 16.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 39% per year over the last three years.
  • Revenues for these companies have grown 27% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market2.71%
Healthcare1.36%
Life Sciences0.97%
Clinical Research and Equipment0.97%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A087010 Peptron₩187.50k16.7%
+₩624.4b
389.6%PS1017x
A141080 LigaChem Biosciences₩114.50k4.9%
+₩192.1b
82.9%PE167x
A445680 Curiox Biosystems₩40.80k22.3%
+₩120.3b
67.6%PS168x
A347740 P&K Skin Research Center₩3.09k7.3%
+₩6.1b
2.3%PE13x
A187660 Hyundai ADM Bio₩1.59k8.6%
+₩5.3b
4.0%PS6.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A002630

₩904.00

ORIENT BIO

7D

-2.3%

1Y

79.4%

A238120

₩3,245.00

Aligned Genetics

7D

2.4%

1Y

-17.7%

A114450

₩3,410.00

Green Lifescience

7D

8.1%

1Y

70.6%

A087010

₩187,500.00

Peptron

7D

16.7%

1Y

389.6%

A141080

₩114,500.00

LigaChem Biosciences

7D

4.9%

1Y

82.9%

A347740

₩3,090.00

P&K Skin Research Center

7D

7.3%

1Y

2.3%

A187660

₩1,588.00

Hyundai ADM Bio

7D

8.6%

1Y

4.0%

A296160

₩6,690.00

Progen

7D

-8.0%

1Y

7.6%

A445680

₩40,800.00

Curiox Biosystems

7D

22.3%

1Y

67.6%

A199730

₩5,510.00

BioInfra

7D

-5.0%

1Y

-40.8%

A383930

₩4,050.00

DT&CRO

7D

-14.6%

1Y

-59.3%

A220100

₩16,190.00

FutureChemLtd

7D

-0.7%

1Y

17.3%

A216400

₩4,300.00

Invites Biocore

7D

-13.9%

1Y

-41.8%

OSZAR »